Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongming Liu

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
The Journal of Thoracic and Cardiovascular Surgery|March 25, 2026
Suppression of fibroblastic activity prolongs cardiac transplant survival through targeting their ATG5 expressionZelai Wu, Bixian Luo, Deqiang Kong, et al.
Iscience|June 16, 2025
Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancerJun He, Hongming Liu, Yansong Dong, et al.
The American Journal of Cardiology|May 12, 2009
Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathyXiaoliang Qiu, Wenling Liu, Dayi Hu, et al.
Respiratory Research|October 30, 2022
Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokersLongyu Shan, Liang Zhang, Xiaolei Zhu, et al.
Zhonghua Nei Ke Za Zhi|February 19, 2016
[The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia]Xin Liu, Wenling Liu, Dayi Hu, et al.
European Journal of Medical Research|February 9, 2023
Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm studyWanjie Wei, Yongliang Tang, Zuxiang Peng, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
The Journal of Thoracic and Cardiovascular Surgery|March 25, 2026
Suppression of fibroblastic activity prolongs cardiac transplant survival through targeting their ATG5 expressionZelai Wu, Bixian Luo, Deqiang Kong, et al.
Iscience|June 16, 2025
Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancerJun He, Hongming Liu, Yansong Dong, et al.
The American Journal of Cardiology|May 12, 2009
Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathyXiaoliang Qiu, Wenling Liu, Dayi Hu, et al.
Respiratory Research|October 30, 2022
Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokersLongyu Shan, Liang Zhang, Xiaolei Zhu, et al.
Zhonghua Nei Ke Za Zhi|February 19, 2016
[The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia]Xin Liu, Wenling Liu, Dayi Hu, et al.
European Journal of Medical Research|February 9, 2023
Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm studyWanjie Wei, Yongliang Tang, Zuxiang Peng, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Pageof 14